Kliniska studier för Gliom i Illinois
13 studier för Gliom söker deltagare vid platser i Illinois.
Städer i Illinois
Officiell studietext (engelska)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- University of Chicago Comprehensive Cancer Center, Chicago
- OSF Children's Hospital of Illinois, Peoria
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 1 okt. 2026 · NCT05099003Targeted Pediatric High-Grade Glioma Therapy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarObservationsstudie
12 Months – 39 Years · Alla kön · Uppdaterad 8 sep. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Chicago, Chicago
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 2
Ålder 3 till 39 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05096481Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 1
Ålder 1 till 25 · Alla kön · Uppdaterad 18 aug. 2026 · NCT04485559Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
RekryterarFas 1/2
Ålder 18 till 130 · Alla kön · Uppdaterad 12 aug. 2026 · NCT05417594A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Northwestern Medicine, Chicago
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 30 juli 2026 · NCT07464925MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 1/2
Ålder 1 till 26 · Alla kön · Uppdaterad 10 juli 2026 · NCT06712875Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarTidig fas 1Friska volontärer välkomna
Ålder 1 till 21 · Alla kön · Uppdaterad 29 juni 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 29 maj 2026 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Northwestern Memorial Hospital, Chicago
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 apr. 2026 · NCT06810544rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
RekryterarFas 1
12 Months – 18 Years · Alla kön · Uppdaterad 17 mars 2026 · NCT04943848Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.